Description: The Fund seeks to track the performance of an index composed of developed and emerging market companies which are generating significant revenues from specific sectors focused on pushing the boundaries in medical treatment and technology.
Exchange: LSE
Country: UK
Currency: US Dollar ($)
Category: Sector Equity Healthcare
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 71.85 | 0.00 | 71.85 |
| Stock non-US | 27.87 | 0.00 | 27.87 |
| Cash | 0.44 | 0.16 | 0.28 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 97.67 | 98.64 |
| Industrials | 0.80 | 0.13 |
| Basic Materials | 0.72 | 0.35 |
| Technology | 0.51 | 0.18 |
| Financial Services | 0.31 | 0.22 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 72.98 | 73.52 |
| Europe Developed | 12.78 | 15.05 |
| Asia Developed | 4.99 | 0.24 |
| Japan | 4.22 | 3.55 |
| Asia Emerging | 3.06 | 2.05 |
| Australasia | 1.63 | 0.49 |
| United Kingdom | 0.34 | 4.96 |
| Latin America | 0.00 | 0.11 |
| Europe Emerging | 0.00 | 0.04 |